Amgen makes regenerative medicine play, backing $25M Fortuna round to move neural stem cells into the clinic – FierceBiotech
|
Amgen makes regenerative medicine play, backing $25M Fortuna round to move neural stem cells into the clinic
FierceBiotech Amgen's VC wing has invested in Fortuna Fix to help move autologous neural stem cells into the clinic. The $25 million series B sets regenerative medicine startup Fortuna up to move candidates against Parkinson's disease and spinal cord injury into the … |
